Acutus Medical (AFIB) Competitors $0.06 0.00 (-1.67%) (As of 12/20/2024 04:34 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsTrends AFIB vs. INBS, TNON, NUWE, POAI, AEMD, CTCX, SINT, STSS, CHEK, and AMIXShould you be buying Acutus Medical stock or one of its competitors? The main competitors of Acutus Medical include Intelligent Bio Solutions (INBS), Tenon Medical (TNON), Nuwellis (NUWE), Predictive Oncology (POAI), Aethlon Medical (AEMD), Carmell (CTCX), Sintx Technologies (SINT), Sharps Technology (STSS), Check-Cap (CHEK), and Autonomix Medical (AMIX). These companies are all part of the "medical equipment" industry. Acutus Medical vs. Intelligent Bio Solutions Tenon Medical Nuwellis Predictive Oncology Aethlon Medical Carmell Sintx Technologies Sharps Technology Check-Cap Autonomix Medical Intelligent Bio Solutions (NASDAQ:INBS) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, community ranking, media sentiment, earnings, analyst recommendations, risk, profitability and valuation. Which has more risk & volatility, INBS or AFIB? Intelligent Bio Solutions has a beta of 4.72, suggesting that its share price is 372% more volatile than the S&P 500. Comparatively, Acutus Medical has a beta of -0.22, suggesting that its share price is 122% less volatile than the S&P 500. Which has stronger earnings and valuation, INBS or AFIB? Intelligent Bio Solutions has higher earnings, but lower revenue than Acutus Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIntelligent Bio Solutions$3.19M1.79-$10.16MN/AN/AAcutus Medical$7.16M0.25-$81.66MN/AN/A Does the MarketBeat Community favor INBS or AFIB? Acutus Medical received 12 more outperform votes than Intelligent Bio Solutions when rated by MarketBeat users. CompanyUnderperformOutperformIntelligent Bio SolutionsN/AN/AAcutus MedicalOutperform Votes1232.43% Underperform Votes2567.57% Do institutionals and insiders hold more shares of INBS or AFIB? 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. Comparatively, 56.9% of Acutus Medical shares are owned by institutional investors. 0.3% of Intelligent Bio Solutions shares are owned by company insiders. Comparatively, 5.2% of Acutus Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media prefer INBS or AFIB? In the previous week, Intelligent Bio Solutions had 3 more articles in the media than Acutus Medical. MarketBeat recorded 3 mentions for Intelligent Bio Solutions and 0 mentions for Acutus Medical. Intelligent Bio Solutions' average media sentiment score of 0.87 beat Acutus Medical's score of 0.00 indicating that Intelligent Bio Solutions is being referred to more favorably in the media. Company Overall Sentiment Intelligent Bio Solutions Positive Acutus Medical Neutral Is INBS or AFIB more profitable? Acutus Medical has a net margin of -272.74% compared to Intelligent Bio Solutions' net margin of -288.35%. Intelligent Bio Solutions' return on equity of -147.50% beat Acutus Medical's return on equity.Company Net Margins Return on Equity Return on Assets Intelligent Bio Solutions-288.35% -147.50% -81.21% Acutus Medical -272.74%-311.64%-11.57% SummaryIntelligent Bio Solutions and Acutus Medical tied by winning 6 of the 12 factors compared between the two stocks. Ad InvestorPlaceWall Street Icon: “You must get on the right side of this thing”I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years.This market shakeup is going to be much more intense. Get Acutus Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AFIB vs. The Competition Export to ExcelMetricAcutus MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.55M$4.34B$5.14B$9.08BDividend YieldN/A44.57%5.09%4.23%P/E RatioN/A25.0190.0517.20Price / Sales0.2545.901,117.09117.04Price / CashN/A43.4443.1037.85Price / Book-1.977.094.784.78Net Income-$81.66M$13.64M$120.31M$225.60M7 Day PerformanceN/A-2.93%-1.92%-1.23%1 Month PerformanceN/A-1.42%13.65%0.46%1 Year PerformanceN/A39.20%28.34%15.24% Acutus Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AFIBAcutus MedicalN/A$0.06-1.7%N/A-68.4%$1.55M$7.16M0.00340Gap DownINBSIntelligent Bio Solutions1.0388 of 5 stars$1.49+0.7%N/A-68.7%$6.54M$3.19M0.0010Positive NewsTNONTenon Medical1.9628 of 5 stars$1.94-1.0%$5.50+183.5%-0.5%$6.09M$2.93M-0.078Positive NewsNUWENuwellis1.6403 of 5 stars$1.19+0.4%$17.00+1,334.6%-95.0%$5.18M$8.86M-0.0159News CoveragePositive NewsPOAIPredictive Oncology2.2425 of 5 stars$0.75-3.8%$3.00+300.0%-76.7%$5M$1.48M-0.2530News CoverageGap UpAEMDAethlon Medical3.0781 of 5 stars$0.35-2.4%$7.00+1,899.4%-69.3%$4.89M$570,000.00-0.1310Analyst ForecastNews CoverageGap UpCTCXCarmell1.2731 of 5 stars$0.21-2.3%N/A-94.5%$4.29M$32,839.000.0014News CoveragePositive NewsSINTSintx Technologies0.4764 of 5 stars$3.02-2.6%N/A-95.3%$4.06M$1.64M-0.0643STSSSharps Technology1.0349 of 5 stars$2.09+2.5%N/AN/A$3.76MN/A-0.253News CoveragePositive NewsCHEKCheck-Cap0.3448 of 5 stars$0.61-2.5%N/A-71.4%$3.58MN/A-0.2180Analyst ForecastNews CoverageGap DownAMIXAutonomix Medical2.9077 of 5 stars$3.06-4.1%$28.00+815.0%N/A$3.53MN/A-0.201News Coverage Related Companies and Tools Related Companies INBS Competitors TNON Competitors NUWE Competitors POAI Competitors AEMD Competitors CTCX Competitors SINT Competitors STSS Competitors CHEK Competitors AMIX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AFIB) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acutus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acutus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AFIB Stock Alerts